Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition

NCT04965688 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT04965688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition
Lead sponsor
Inova Health Care Services
Phase
Phase 2
Overall status
Terminated
Start date
August 8, 2021
Completion date
March 13, 2024
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen receptor-positive breast cancer, her2-negative breast cancer